Related Experiment Video

Updated: Jun 24, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Targeting TGFbeta-mediated processes in cancer

Maria Fiammetta Romano1

  • 1Department of Biochemistry and Medical Biotechnologies, Federico II University, via Pansini 5, 80131 Naples, Italy. romano@dbbm.unina.it

Current Opinion in Drug Discovery & Development
|April 1, 2009
PubMed

Insights

Transforming growth factor beta (TGFbeta) plays key roles in development and homeostasis. Aberrant TGFbeta signaling contributes to cancer, prompting the development of targeted therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Transforming growth factor beta (TGFbeta) is a crucial cytokine regulating embryonic development and tissue homeostasis.
  • TGFbeta signaling is vital for epithelial, neural, and immune system differentiation and function.
  • Autocrine and paracrine TGFbeta-mediated processes are increasingly implicated in various cancers.

Purpose of the Study:

  • To review the causes of TGFbeta malfunction in cancer.
  • To present the rationale for targeting TGFbeta therapeutically in human neoplasia.
  • To outline molecular strategies for modulating TGFbeta signaling in cancer treatment.

Main Methods:

  • Literature review of studies on TGFbeta in cancer.
  • Analysis of TGFbeta's role in different tumor types and stages.
  • Examination of molecular mechanisms underlying TGFbeta dysregulation.

Main Results:

  • TGFbeta malfunction is a significant factor in cancer development and progression.
  • Targeting TGFbeta offers a promising therapeutic strategy for various human neoplasms.
  • Understanding molecular pathways is key to developing effective TGFbeta-modulating therapies.

Conclusions:

  • TGFbeta dysregulation contributes to oncogenesis.
  • Therapeutic targeting of TGFbeta pathways holds potential for cancer treatment.
  • Further research into molecular strategies is essential for successful clinical application.

More Related Videos

Spheroid Assay to Measure TGF-β-induced Invasion09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...